Drug sensitivity experiments revealed that EMC2 overexpression sensitizes breast cancer cells to PDK1 or AKT inhibition both in vitro and in vivo, whereas EMC2 silencing has the opposite effect. The gene discussed is EMC2; the disease is breast cancer.